Breunig, C., & Hoffmann, K. (2014). BRaf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinoma. Clinical cancer research, 20(9), . https://doi.org/10.1158/1078-0432.CCR-13-1635
Chicago-Zitierstil (17. Ausg.)Breunig, Christian, und Katrin Hoffmann. "BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma." Clinical Cancer Research 20, no. 9 (2014). https://doi.org/10.1158/1078-0432.CCR-13-1635.
MLA-Zitierstil (9. Ausg.)Breunig, Christian, und Katrin Hoffmann. "BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular Carcinoma." Clinical Cancer Research, vol. 20, no. 9, 2014, https://doi.org/10.1158/1078-0432.CCR-13-1635.